AN INVESTIGATOR-INITIATED, PHASE 4, OPEN-LABEL, SINGLE-ARM, SINGLE-CENTER STUDY INVESTIGATING THE TISSUE-RESIDENT MEMORY T-CELLS AND DISEASE MEMORY IN PSORIASIS SKIN DURING GUSELKUMAB TREATMENT. THE GUSMEM STUDY. - GUSMEM01
Latest Information Update: 03 Sep 2025
At a glance
- Drugs Guselkumab (Primary)
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- Acronyms GUSMEM01
Most Recent Events
- 03 Sep 2025 New trial record